Literature DB >> 2732029

Longitudinal study of acuity and stereopsis in infants with or at-risk for esotropia.

V Dobson1, S L Sebris.   

Abstract

Grating acuity and stereopsis were measured longitudinally in five groups of infants: infantile esotropes, moderate hyperopes, high hyperopes, infants with a family history of strabismus or amblyopia and controls. Grating acuity was measured with a forced-choice preferential looking procedure. Stereopsis was assessed with a random-element stereogram. Testing was conducted when subjects were 3, 6, 9, 12, 18, 24, 30 and 36 months of age. No differences among groups in absolute acuity scores or interocular acuity differences were found until the infants reached 30 and 36 months of age. At these ages, treated infantile esotropes showed acuity scores that were, on average, 0.5 octave poorer than those of controls for both the eye showing the better acuity and the eye showing the worse acuity. Stereopsis testing indicated that few, if any, of the infantile esotropes showed stereopsis at any of the test ages. Over 30% of the high hyperopes developed strabismus by age 3 years, but none of the infants in the moderate hyperopia or family history groups developed strabismus.

Entities:  

Mesh:

Year:  1989        PMID: 2732029

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  16 in total

Review 1.  Why do only some hyperopes become strabismic?

Authors:  Erin Babinsky; T Rowan Candy
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-24       Impact factor: 4.799

2.  Movement hyperacuity in childhood amblyopia.

Authors:  S L Kelly; T J Buckingham
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

3.  Associations between hyperopia and other vision and refractive error characteristics.

Authors:  Marjean Taylor Kulp; Gui-Shuang Ying; Jiayan Huang; Maureen Maguire; Graham Quinn; Elise B Ciner; Lynn A Cyert; Deborah A Orel-Bixler; Bruce D Moore
Journal:  Optom Vis Sci       Date:  2014-04       Impact factor: 1.973

4.  Visual Function of Moderately Hyperopic 4- and 5-Year-Old Children in the Vision in Preschoolers - Hyperopia in Preschoolers Study.

Authors:  Elise B Ciner; Marjean Taylor Kulp; Maureen G Maguire; Maxwell Pistilli; T Rowan Candy; Bruce Moore; Gui-Shuang Ying; Graham Quinn; Gale Orlansky; Lynn Cyert
Journal:  Am J Ophthalmol       Date:  2016-07-29       Impact factor: 5.258

5.  Monocular visual outcome in untreated early onset esotropia.

Authors:  W V Good; L C da Sa; C J Lyons; C S Hoyt
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

6.  Effect of gestational age and birth weight on the risk of strabismus among premature infants.

Authors:  Shilpa Gulati; Chris A Andrews; Alexandra O Apkarian; David C Musch; Paul P Lee; Joshua D Stein
Journal:  JAMA Pediatr       Date:  2014-09       Impact factor: 16.193

Review 7.  Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children.

Authors:  Lisa Jones-Jordan; Xue Wang; Roberta W Scherer; Donald O Mutti
Journal:  Cochrane Database Syst Rev       Date:  2014-08-18

8.  A Randomized Clinical Trial of Immediate versus Delayed Glasses for Moderate Hyperopia in 1- and 2-Year-Olds.

Authors:  Marjean T Kulp; Jonathan M Holmes; Trevano W Dean; Donny W Suh; Raymond T Kraker; David K Wallace; David B Petersen; Susan A Cotter; Ruth E Manny; Rosanne Superstein; Tawna L Roberts; John M Avallone; Deborah R Fishman; S Ayse Erzurum; David A Leske; Alex Christoff
Journal:  Ophthalmology       Date:  2019-01-04       Impact factor: 12.079

9.  Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children.

Authors:  Lisa Jones-Jordan; Xue Wang; Roberta W Scherer; Donald O Mutti
Journal:  Cochrane Database Syst Rev       Date:  2020-04-02

Review 10.  Stereoacuity outcomes after treatment of infantile and accommodative esotropia.

Authors:  Eileen E Birch; Jingyun Wang
Journal:  Optom Vis Sci       Date:  2009-06       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.